Home

Lupus nephritis

Lupus and Kidney Disease (Lupus Nephritis) NIDD

  1. Lupus nephritis is a type of kidney disease caused by systemic lupus erythematosus (SLE or lupus). Lupus is an autoimmune disease —a disorder in which the body's immune system attacks the body's own cells and organs
  2. Lupus nephritis (LN) is a form of glomerulonephritis that constitutes one of the most severe organ manifestations of the autoimmune disease systemic lupus erythematosus (SLE). Most patients with SLE who develop LN do so within 5 years of an SLE diagnosis and, in many cases, LN is the presenting mani
  3. Lupus nephritis is an inflammation of the kidneys caused by systemic lupus erythematosus (SLE), an autoimmune disease. It is a type of glomerulonephritis in which the glomeruli become inflamed
  4. Lupus nephritis is one of the most serious complications of systemic lupus erythematosus (SLE). It occurs when the immune system mistakenly attacks the kidneys, leading to inflammation and possibly to organ damage

When present, lupus nephritis (LN) typically develops earlier in the disease course. (See 'Epidemiology' above.) Although LN is considered to be a classic form of immune complex glomerulonephritis, the pathogenesis of LN can involve a variety of mechanisms. These mechanisms include the expression of genes leading to neutrophil activation, increased expression of genes for interferon and other pro-inflammatory mediators in myeloid and other immune cell populations, release of neutrophil. Lupus nephritis is inflammation of the kidney that is caused by systemic lupus erythematous (SLE). Also called lupus, SLE is an autoimmune disease. With lupus, the body's immune system targets its.. Symptoms of lupus nephritis often include weight gain; swelling in the legs, feet, or ankles; and urine that is foamy, bubbly, or frothy. Additional signs and symptoms associated with the different classes of lupus nephritis are noted below SLE is a chronic inflammatory disease that affects the kidneys in about 50% of patients. Lupus nephritis is a major risk factor for overall morbidity and mortality in SLE, and despite potent anti-inflammatory and immunosuppressive therapies still ends in CKD or ESRD for too many patients Lupus nephritis • Renal involvement is a major cause of morbidity and hospital admissions in SLE patients and occurs in 40% to 70% of all patients. • Generally, renal involvement tends to occur within the first 2 years of SLE with its frequency decreasing significantly after the first 5 years of disease

When your kidneys become affected, it is called lupus nephritis. Lupus nephritis happens when your immune system attacks your kidneys. The most severe kind of lupus nephritis is proliferative nephritis, which can cause permanent damage to your kidneys. Many experts believe the cause of lupus is a combination of genetic and environmental factors Lupus nephritis is a serious and potentially life-threatening type of kidney disease caused by lupus. About half of people with lupus will develop lupus nephritis. One out of 10 will develop end-stage renal disease due to lupus nephritis. It usually develops in the first 5 years after lupus symptoms first appear. 1,2 Lupus nephritis is one of the most serious complications of lupus. It occurs when SLE causes your immune system to attack your kidneys — specifically, the parts of your kidney that filter your.. Lupus nephritis occurs in up to 80% of patients with SLE and is associated with significantly reduced survival. Interestingly, one of the first studies to describe lupus nephritis was written approximately 50 years ago and was the first to utilize kidney biopsies to classify lupus nephritis based on histologic findings

Pediatric lupus nephritis - Brazilian Journal of

Lupus nephritis (LN) is a form of glomerulonephritis that constitutes one of the most severe organ manifestations of the autoimmune disease systemic lupus erythematosus (SLE). Most patients with. Systemic lupus erythematosus (SLE) that affects the kidneys is called lupus nephritis. Lupus is an autoimmune disease, meaning your immune system (your body's defense system), which usually protects the body from disease, turns against the body. This causes harm to organs and tissues, like your kidneys Lupus nephritis and renal involvement in other rheumatologic diseases. Lupus nephritis - Rheumatoid arthritis - Mixed connective tissue disease - Progressive systemic sclerosis - Sjögren syndrome . LUPUS NEPHRITIS. Systemic lupus erythematous (SLE) is a multisystemic disease in which there is production of autoantibodies and immune complexes formation

Lupus nephritis - PubMe

Lupus Nephritis - Medical PowerPoint Presentation - YouTube

Lupus nephritis - Wikipedi

  1. Among patients with lupus nephritis with impaired renal function or arterial hypertension (except in pregnancy), renin-angiotensin-aldosterone system blockers were recommended by the task force. Vaccination, particularly against influenza and Streptococcus pneumoniae, was strongly recommended
  2. Lupus nephritis, which is a kidney disorder, is a complication of systemic lupus erythematosus
  3. What is lupus nephritis? When lupus causes the immune system to attack and inflame your kidneys, it's called lupus nephritis. This inflammation can keep your kidneys from working properly. If left untreated, lupus nephritis can lead to permanent kidney damage
  4. Lupus nephritis is inflammation in the kidneys that can make them stop working. When the kidneys aren't working well, waste builds up in the blood and extra water builds up in the body. Lupus nephritis is most common in people ages 20 to 40. It usually starts within 5 years of your first lupus symptoms
  5. Lupus nephritis is an inflammation of the kidney caused by the rheumatic condition systemic lupus erythematosus (SLE). Lupus affects the skin, joints and brain as well as the kidneys. An estimated one-third of people with lupus will develop nephritis that requires medical evaluation and treatment
  6. Tests to diagnose lupus nephritis include: Blood and urine tests. In addition to standard blood and urine tests, you may be asked to collect your urine for an entire day. These tests measure how well your kidneys are working. Kidney biopsy. A biopsy — where your doctor removes a small section of kidney tissue for lab analysis — is the most.

What is lupus nephritis? Lupus Foundation of Americ

The term 'lupus' refers to systemic lupus erythematosus, 'nephritis' refers to the 'nephron,' the Greek word for kidney, and 'itis' means inflammation, so lupus nephritis refers to inflammation of the kidney that results from having systemic lupus erythematosus. Lupus is an autoimmune disease in which the immune system attacks various parts of the body, including the skin. Lupus nephritis (LN) is a common and severe manifestation of systemic lupus erythematosus (SLE). LN is a glomerulonephritis characterized by the accumulation of immune complexes in glomeruli and often an inflammatory response in all kidney compartments. Over time inflammation leads to chronic damage of the renal parenchyma and loss of kidney.

Lupus nephritis: Diagnosis and classification - UpToDat

Lupus Nephritis: Diagnosis, Symptoms, Treatment

Lupus Nephritis Histology Predicts Long-Term Outcomes

Lupus Nephritis Classes, Signs, and Symptoms ALL IN for

Lupus nephritis is a complication in patients with systemic lupus erythematosus (SLE), an autoimmune condition causing inflammation of the body's tissues.Lupus nephritis targets the kidneys, causing damage and inflammation, which prevents normal function and may lead to kidney failure We present a consensus report pertaining to the improved clarity of definitions and classification of glomerular lesions in lupus nephritis that derived from a meeting of 18 members of an international nephropathology working group in Leiden, Netherlands, in 2016. Here we report detailed recommendations on issues for which we can propose adjustments based on existing evidence and current. Lupus Community Feedback The LUPKYNIS approval marks a turning point for the lupus nephritis community - patients, caregivers, families, and healthcare professionals - all of whom we thank for their partnership in the development of this innovative novel treatment Lupus nephritis is a common and dangerous complication of lupus marked by inflammation that can lead to damage and possible failure of the kidney. While up t.. • The histologic type of lupus nephritis that develops depends on numerous factors, including the antigen specificity and other properties of the autoantibodies and the type of inflammatory response . • The immune deposits in lupus nephritis occur in the mesangium, subendothelial, and/or subepithelial compartments of the glomerulus 6

Lupus nephritis - Advanced definition. Lupus nephritis is a specific type of inflammation in the kidneys known as a glomerulonephritis. In this type of disease, the glomeruli are inflamed. The glomerulus is a network of tiny tubes that transport blood, known as capillaries. It is found at the beginning of the nephron in the kidney Lupus nephritis (LN) is a severe manifestation of SLE, characterised by subendothelial and/or subepithelial immune complex depositions in the afflicted kidney, resulting in extensive injury and nephron loss during the acute phase and eventually chronic irreversible damage and renal function impairment if not treated effectively. The therapeutic management of LN has improved during the last. Lupus nephritis (LN) is one of the most serious complications of systemic lupus erythematosus (SLE) since it is the major predictor of poor prognosis. In susceptible individuals suffering of SLE, in situ formation and deposit of immune complexes (ICs) from apoptotic bodies occur in the kidneys as a result of an amplified epitope immunological response Various tests will be needed to confirm or rule out lupus nephritis: Urine tests to see if protein is present in the urine Blood tests to check kidney function and specific lupus tests Kidney biopsy to see if any areas contain inflammation Other tests may also be needed if the results of these tests.

Lupus nephritis is the most common side effect of the autoimmune condition lupus. And after years with no new treatments, scientists say there are promising new drugs that can stop the kidney damage with fewer toxic side effects Lupus nephritis is inflammation of the kidney where they can't function normally, caused by Systemic Lupus Erythematous (SLE) attacking its own tissues. Left untreated it can lead to kidney failure and is one of the more severe features of SLE. Up to 60% of SLE patients can develop this complication. The symptoms vary widely between patients. Emory Medicine Grand Rounds - 2/7/2017TOPIC: The Management of Lupus Nephritis: A Nephrologist's PerspectiveLEARNING OBJECTIVES:• Understand testing to di.. Background on lupus nephritis: - Systemic lupus erythematosus (SLE) is an autoimmune disease where the immune system attacks the person's own body. - Around 40% of the time, it will attack the kidneys. This is called lupus nephritis (LN). - It causes no symptoms whatsoever until it is severe and permanent damage is already occurring Lupus nephritis is a serious chronic disease, one that has a disproportionately large impact on Black, Hispanic, and other communities of color in the US. Both belimumab and voclosporin are important new treatment options. Despite remaining uncertainty about both treatments' longer-term outcomes, their estimated prices appear to be aligned.

The largest and longest Phase III trial in LN: 2-year duration 1. BENLYSTA is the first and only FDA-approved treatment for lupus nephritis studied with both MMF and CYC. LN = lupus nephritis; ORR = overall response rate. § Confirmed biopsy-proven Class III, IV, V or V in combination with III or IV Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that predominantly affects women of childbearing age. The exact cause is still unknown, but hormonal and immunological features as well as genetic predisposition are considered likely etiological factors. The presentation of the disease is variable but usually characterized. Lupus is a heterogenous multisystem autoimmune disease whereby nephritis is one of its most common cause of overall morbidity and mortality. Accurate, timely diagnosis and effective treatment in lupus nephritis (LN) remains a challenge to many clinicians including those who are directly involved in the daily care of these patients. Despite significant improvement in patients' survival rate. Systemic lupus erythematosus (SLE) is an autoimmune disease with multisystem involvement and no cure. Among patients with SLE, roughly 50% develop lupus nephritis and are at risk of developing lupus nephritis-related end-stage kidney disease (ESKD).Current therapies for lupus nephritis broadly inhibit immune system activity, although these interventions may fail to achieve full responses.

BLyS is elevated in lupus patients, is locally expressed at the level of the kidney in lupus nephritis, and levels may correlate with disease activity 1-4. Belimumab, a fully human monoclonal IgG1 antibody, neutralizes BLyS and subsequently depletes the autoreactive B cell pool contributing to the pathogenic autoimmune milieu of lupus What are the complications of lupus nephritis? 10-30% of people with lupus nephritis go on to develop end-stage kidney disease (ESKD), also known as kidney failure, within 15 years of diagnosis. Early diagnosis and treatment may help prevent long-term kidney damage, however, even with medications, the kidneys may need more support

Serum autoantibodies to native DNA are a specific diagnostic criterion for SLE,2 and a prognostic factor for the development of lupus nephritis (LN) that affects 30%-60% of patients.3 However, the earliest reports of antibody responses to nucleic acids/nucleoproteins were documented in association with clinically apparent bacterial infections. SLE is a complex autoimmune disease with genetic, epigenetic, immune-regulatory, environmental and hormonal factors. Kidney inflammation and injury, termed lupus nephritis (LN), occurs in over half of patients with SLE and is a leading cause of disability and death. There is a high degree of short-term and long-term side effects associated with current LN therapies and they are not effective. An ideal biomarker for lupus nephritis should possess the following properties: good correlation with renal activity as reflected by the degree of proteinuria and urine sediments, sensitive to change so that it can be used for serial monitoring of disease activity in the kidneys and defining treatment response and clinical remission, ability to. Lupus nephritis (LN) may be observed in up to 50% of patients with systemic lupus erythematosus (SLE) and is associated with a poor prognosis ().Although renal response rates among patients receiving standard treatment of proliferative LN may approach 50-80% at 1 year, many of these responses are only partial (2-4).Therefore, therapeutic regimens that are more effective are needed () Lupus nephritis is one of the leading causes of mortality for patients with systemic lupus erythematosus (SLE), and patients with both SLE and end-stage renal disease have standardized mortality ratios more than 60 times that of patients with SLE with normal kidney function. 1 Lupus nephritis causes irreversible kidney damage and is associated with renal failure, cardiac events and death. 2.

Lupus nephritis increases the morbidity and mortality associated with systemic lupus erythematosus. The long-term follow-up of affected patients has demonstrated that focal and diffuse. BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. BENLYSTA IV is approved in children aged 5 years and older with SLE on other lupus medicines Lupus Nephritis and Pregnancy: Concerns and Management. Semin Nephrol. 2017 Jul. 37 (4):347-353. . Moroni G, Doria A, Giglio E, Tani C, Zen M, Strigini F, et al. Fetal outcome and recommendations. Conditions: We Aim to Examine the Predictors of Sustained Complete Renal Remission in Patients With Lupus Nephritis at Sohag University Hospital. NCT01845740. Completed. Phase Ib Study of SC Milatuzumab in SLE. Conditions: Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Discoid, Lupus Erythematosus, Systemic, Lupus Vasculitis, Central.

Among patients with lupus nephritis, a combination of voclosporin, mycophenolate mofetil (MMF), and low-dose steroids vs MMF and low-dose steroids alone provides a clinically and statistically superior renal response rate, according to study results published in the Lancet.. The double-blind, phase 3 trial (ClinicalTrials.gov Identifier: NCT03021499) was conducted in 142 hospitals and clinics. In the early stages of lupus nephritis lupus nephritis: Lupus nephritis is a possible complication of lupus that occurs when lupus autoantibodies affect structures in the kidneys that filter out waste. This causes kidney inflammation and may lead to blood in the urine, protein in the urine, high blood pressure, impaired kidney function, or even.

lupus rash - lupus nephritis - YouTube

Update on Lupus Nephritis American Society of Nephrolog

Systemic lupus erythematosus (SLE), a chronic autoimmune disease characterized by loss of immune tolerance, leads to multisystem inflammation and organ injury. 1-4 Lupus nephritis, which occurs in. To determine whether enhanced B-cell depletion with obinutuzumab could improve responses in lupus nephritis, Furie and colleagues randomized patients with class 3/4 lupus nephritis (n=125) to. Systemic lupus erythematosus is a multisystem autoimmune disease that commonly affects the kidneys. Lupus nephritis (LN) is the most common cause of kidney injury in systemic lupus erythematosus and a major risk factor for morbidity and mortality. The pathophysiology of LN is heterogeneous. Genetic and environmental factors likely contribute to this heterogeneity

lupus nephritis - SlideShar

Systemic Lupus Erythematosus: Primary Care Approach to

BOSTON, January 22, 2021 - The Institute for Clinical and Economic Review today released a Draft Evidence Report assessing the comparative clinical effectiveness and value of voclosporin (Aurinia Pharmaceuticals) and belimumab (Benlysta®, GlaxoSmithKline) for the treatment of lupus nephritis. This preliminary draft marks the midpoint of ICER's eight-month process of assessing these. View this document on Scribd. 2019 Update of the Joint European League A gainst Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis Fanouriakis A, Kostopoulou M, Cheema K, et al 2019 Annals of the Rheumatic Diseases 2020;79:713-723 This class is divided into diffuse segmental (IV-S) lupus nephritis when ≥50% of the involved glomeruli have segmental lesions, and diffuse global (IV-G) lupus nephritis when ≥50% of the involved glomeruli have global lesions. Segmental is defined as a glomerular lesion that involves less than half of the glomerular tuft Tagged Lupus Nephritis Treatment 12月 · 20 سوف المرضى الذين يعانون من الكرياتينين 640 مع مرض الذئبة التهاب الكلية يوصي غسيل الكل Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis (TULIP-LN1) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government

Lupus nephritis - Symptoms, Treatment and Complications

Lupus nephritis: Lupus is an autoimmune disease, which means that the immune system mistakenly attacks healthy tissues in the body. Over half of all individuals with a lupus diagnosis eventually. Other treatments that are used for lupus nephritis, but are still unproven or controversial, include: plasmapheresis, intravenous immunoglobulin infusions, and fish oils containing omega-3 fatty acids Purpose of review . The management of lupus nephritis remains unsatisfactory due to insufficiently effective treatment regimens and the dearth of reliable predictors of disease onset or progression to guide individualized therapeutic decisions. This review summarizes new findings related to lupus nephritis over the last 18 months and discusses clinical needs that should be considered to. Objectives To develop recommendations for the management of adult and paediatric lupus nephritis (LN). Methods The available evidence was systematically reviewed using the PubMed database. A modified Delphi method was used to compile questions, elicit expert opinions and reach consensus. Results Immunosuppressive treatment should be guided by renal biopsy, and aiming for complete renal. Lupus nephritis is a type of kidney disease caused by systemic lupus erythematosus (SLE), or lupus, a chronic, autoimmune disease in which the immune system mistakenly attacks the body's tissues, causing inflammation and organ damage. Lupus is characterized by painful or swollen joints, muscle pain, extreme fatigue, unexplained fever, and.

Treatment Options for Lupus Nephritis

What is Lupus Nephritis

Lupus nephritis is histologically evident in most patients with SLE, even those without clinical manifestations of renal disease. The symptoms of lupus nephritis are generally related to. Lupus nephritis is an inflammation of the kidney caused by Systemic Lupus Erythematosus - resulting in irreversible kidney damage and increasing the risk of kidney failure, cardiac events, and death

Lupus Nephritis: Symptoms, Stages, and Mor

Lupus nephritis is an inflammation of the kidney caused by systemic lupus erythematosus. Women with lupus nephritis have worse pregnancy outcomes than the general population The optimal treatment of lupus nephritis (LN) varies with the type of renal histology that is present in renal biopsy specimens. Immunosuppressive therapy is indicated in patients with active diffuse or focal proliferative LN (class III or IV LN) [ 1-3 ]. Immunosuppressive therapy is usually not indicated for minimal mesangial and mesangial.

Lupus Nephritis - Landmark Nephrolog

It is now also prescribed for people who suffer from inflammation of the kidney caused by lupus, otherwise known as lupus nephritis. However, cyclosporine can be toxic to the kidneys, so use of this medication is usually reserved for cases in which a person's lupus does not respond to other immunosuppressive medications like Cellcept Lupus nephritis is the most common side effect of the autoimmune condition lupus. It's the disease that caused actress and musician Selena Gomez to undergo a kidney transplant and raised public. Aurinia estimates that of the half-million lupus patients in the U.S., about 80,000 to 100,000 progress to lupus nephritis, which can lead to kidney failure, dialysis, transplant and even death Lupus nephritis is an inflammation of the kidney which is caused by systemic lupus erythematous (SLE). Also called lupus, SLE is an autoimmune disease. With lupus, the body's immune system targets its own body tissues. Lupus nephritis happens when lupus involves the kidneys. Up to 60% of lupus patients will develop lupus nephritis Lupus nephritis refers to the kidney damage caused by the disease lupus erythematosus. Lupus erythematosus is an autoimmune disease where the immune system turns against the body, affecting vital organs. Systemic lupus erythematosus affects the kidneys, joints, skin, and brain and can be fatal. While the primary cause of the disease is unknown.

Lupus nephritis Nature Reviews Disease Primer

Renal involvement represents a severe complication of Systemic Lupus Erythematosus (SLE) and biopsy-proven lupus nephritis (LN) occurs in 20-40% of patients [1,2,3].The management of LN has witnessed advances over the past decades thus resulting in improved outcomes [4, 5].Still, a considerable proportion (10-30%) of patients will develop chronic renal insufficiency and/or end-stage renal. Urine Proteomics in Lupus Nephritis: Implications for a Liquid Biopsy: Andrea Fava, MD. Up to 50-70% of patients with SLE can develop lupus nephritis or kidney inflammatory disease. There is no FDA-approved treatment for lupus nephritis at this time. Current evaluation of patients with nephritis includes measuring total protein amounts in their. After promising 18-month outcomes in patients with proliferative lupus nephritis, obinutuzumab showed sustained benefits through 2 years of treatment for patients burdened with the rheumatic disease.. In new data from the NOBILITY trial, presented at the American College of Rheumatology (ACR) Convergence 2020, an international team of investigators reported that the type 2 anti-CD20 monoclonal.

CALIBRATE: A Clinical Trial for Lupus Nephritis . CALIBRATE is a clinical research study testing the safety and efficacy of an investigational drug approach in lupus nephritis: treatment with rituximab (Rituxan®) and cyclophosphamide (Cytoxan®) followed by belimumab (Benlysta®) About lupus nephritis Systemic lupus erythematosus (SLE), the most common form of lupus, is a chronic, incurable, autoimmune disease. It is difficult to diagnose and even more challenging to treat. The condition is associated with a range of debilitating symptoms that can fluctuate over time, including painful or swollen joints, extreme fatigue. Current treatment recommendations for lupus nephritis are largely guided by the 2003 International Society of Nephrology/Renal Pathology Society classification system. Here, the authors discuss. Introduction. Lupus nephritis (LN) is a common severe complication of systemic lupus erythematosus (SLE) and a major determinant of morbidity and mortality. 1 Up to 60% of adult patients with SLE 2,3 develop renal disease of differing severity during the course of their illness. Despite the introduction of corticosteroids and other immunosuppressive agents which have profoundly changed the. A total of 553 adults with biopsy-confirmed lupus nephritis were randomized 1-to-1 to receive either 23.7 mg Lupkynis or placebo twice daily alongside standard therapy. In addition, all patients. Voclosporin is an investigational drug, being developed by Aurinia Pharmaceuticals, as a treatment for lupus nephritis. It works by blocking the activity of the enzyme calcineurin. The immune system is a complex network that is tightly regulated to ensure a correct response when threatened by an external offender

  • السبعة الرائعون IMDb.
  • شرح قصيدة المؤنسة كاملة.
  • رحال عبادي كلمات.
  • ESBL bacteria treatment.
  • العصر الجليدي.
  • فوائد الشوكولاتة الداكنة للرجيم.
  • فوائد قشر الجوز الأخضر لصبغ الشعر.
  • مستقبل الفيزياء الطبية في العراق.
  • سوبر هيرو معنى.
  • تفسير إذا برق البصر وخسف القمر وجمع الشمس والقمر.
  • طريقة عمل موكا بارد بالنسكويك.
  • المنخفض السوداني.
  • ماهي الأعداد الصحيحة.
  • مدة امتصاص الماء في المعدة.
  • عرض مطعم اسماك ريزو الفيوم.
  • طريقة مسك القطط.
  • مواصفات امبالا 2016 LTZ.
  • الماريجوانا فوائد.
  • حفظ التطبيقات.
  • 3D PowerPoint templates.
  • Lupus nephritis.
  • سعر تيجوان ٢٠٢١.
  • أنواع اتخاذ القرار.
  • البطاطس المسلوقه كم نقطة.
  • دول تحت التاج البريطاني.
  • الحضارة الفرعونية pdf.
  • ممثل مصري شعره أبيض.
  • الكلمات الأكثر بحثا في جوجل الأردن.
  • طريقة رسم الحمامة.
  • حجم شاشة ايفون Xs.
  • غسول بيتادين للحكه.
  • سعر سوني z2 مستعمل في مصر.
  • فوائد الهيل للحمل.
  • كيفية إنشاء ملف على سطح المكتب.
  • قوانين الجبر.
  • هونداي جالوبر للبيع.
  • خلفيات خفيفة.
  • أسماء القضاة الجدد.
  • سعر موبايل تكنو C9.
  • يو تو انجوي.
  • شركة امازون للسياحة.